Human Health Holdings Limited (HKG:1419)
Hong Kong · Delayed Price · Currency is HKD 0.8200
+0.0100 (1.23%)
At close: Feb 13, 2026
Human Health Holdings Cash Flow Statement
Financials in millions HKD. Fiscal year is July - June.
Millions HKD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 26.34 | 24.19 | 180.84 | 375.31 | 144.45 |
Depreciation & Amortization | 67.71 | 68.01 | 74.79 | 63.07 | 67.6 |
Loss (Gain) From Sale of Assets | 0.08 | -0.01 | 0.31 | -0.03 | 2.57 |
Asset Writedown & Restructuring Costs | 11.61 | 18.73 | 63.15 | 10 | - |
Loss (Gain) From Sale of Investments | -2.28 | -16.58 | 6.27 | -25.52 | -2.63 |
Loss (Gain) on Equity Investments | 0.24 | 1.27 | 1.54 | 1.98 | -0.99 |
Stock-Based Compensation | - | - | 0.01 | 0.07 | 0.23 |
Provision & Write-off of Bad Debts | -0.23 | -0.77 | 0.19 | 1.1 | 10.66 |
Other Operating Activities | -0.6 | -102.06 | 10.19 | 64.5 | 17.86 |
Change in Accounts Receivable | -13.81 | 58.7 | 320.52 | -189.95 | -208.12 |
Change in Inventory | 6.68 | -4.42 | -9.92 | -4.43 | -1.97 |
Change in Accounts Payable | 12.1 | -5.72 | 16.98 | 6.18 | 15.07 |
Change in Unearned Revenue | -3.62 | -8.35 | 23.39 | -1.68 | 3.8 |
Change in Other Net Operating Assets | -5.61 | -19.79 | -24.01 | -4.79 | 36.97 |
Operating Cash Flow | 98.6 | 13.21 | 664.26 | 295.81 | 85.49 |
Operating Cash Flow Growth | 646.60% | -98.01% | 124.55% | 246.01% | 128.00% |
Capital Expenditures | -7.77 | -39.51 | -84.02 | -76.52 | -14.05 |
Sale of Property, Plant & Equipment | - | 0.02 | - | 0.14 | 0.33 |
Cash Acquisitions | -33.81 | - | 0.06 | - | - |
Sale (Purchase) of Real Estate | - | - | - | -26.34 | - |
Investment in Securities | 45.48 | -7.34 | -250.13 | -100.14 | 9.71 |
Other Investing Activities | -0.18 | -0.8 | -1.25 | -0.36 | -0.76 |
Investing Cash Flow | 3.71 | -47.64 | -335.34 | -203.22 | -4.77 |
Short-Term Debt Issued | - | - | - | 35.52 | - |
Total Debt Issued | - | - | - | 35.52 | - |
Short-Term Debt Repaid | -23.43 | -4.97 | -5.71 | -4.96 | -3.89 |
Long-Term Debt Repaid | -54.53 | -50.97 | -50.78 | -49.63 | -51.99 |
Total Debt Repaid | -77.96 | -55.94 | -56.49 | -54.59 | -55.89 |
Net Debt Issued (Repaid) | -77.96 | -55.94 | -56.49 | -19.07 | -55.89 |
Common Dividends Paid | -10.63 | -60.73 | -113.86 | -45.55 | -0.54 |
Other Financing Activities | -6.34 | -7.86 | -7.93 | -2.83 | -2.87 |
Financing Cash Flow | -94.93 | -124.52 | -178.29 | -67.45 | -59.3 |
Foreign Exchange Rate Adjustments | 0.12 | -0.06 | -1.26 | -0.17 | 0.58 |
Net Cash Flow | 7.5 | -159.01 | 149.38 | 24.97 | 22 |
Free Cash Flow | 90.83 | -26.3 | 580.24 | 219.3 | 71.44 |
Free Cash Flow Growth | - | - | 164.59% | 206.97% | 174.43% |
Free Cash Flow Margin | 14.09% | -4.45% | 57.92% | 19.55% | 10.91% |
Free Cash Flow Per Share | 0.24 | -0.07 | 1.53 | 0.58 | 0.19 |
Cash Interest Paid | 6.34 | 7.86 | 7.93 | 2.83 | 2.87 |
Cash Income Tax Paid | 10.5 | 112.12 | 55.4 | 4.89 | 4.18 |
Levered Free Cash Flow | 53.69 | -62.87 | 528.29 | 131.96 | 15.24 |
Unlevered Free Cash Flow | 57.78 | -57.73 | 533.47 | 133.8 | 17.07 |
Change in Working Capital | -4.26 | 20.43 | 326.97 | -194.66 | -154.25 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.